In a nutshell This study looked at whether a treatment known as radiofrequency ablation is useful in treating cancer which has spread to a patient’s adrenal glands. Some background The adrenal glands sit on top of the kidneys and make several hormones for the body. Chemotherapy or radiotherapy are often...
Read More
In a nutshell This study looked at whether crizotinib and then ceritinib helped improve survival rates in patients with lung cancer. Some background Anaplastic lymphoma kinase (ALK) is an important protein involved in cell development. It is estimated that genetic changes that alter the function of ALK are found in 3-5% of all non-small cell lung...
Read MoreIn a nutshell This study looked at whether certain risk factors could identify patients who may experience severe lung disease from the chemotherapy used to treat their lung cancer. Some background Interstitial lung disease (ILD) is a scarring of the lung tissue, which makes it hard to breathe. Some patients who already have ILD are at...
Read More
In a nutshell This study looked at the risks of lung cancer recurrence (return after treatment) and mortality rates following recurrence. Some background Treatment for early-stage lung cancer (cancer that has not spread to other areas) typically involves a combination of surgery, chemotherapy and radiation. Patients usually receive...
Read More
In a nutshell This study looked at Asian patients with non-small cell lung cancer (NSCLC) and compared the use of two drug regimens to see which was better. Some background Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Some patients with NSCLC have a genetic mutation in a specific gene, the epidermal growth factor...
Read More
We’ve gotten used to thinking about having cancer in your colon or lung or breast. We’ve systematized treatments and research of cancer by the organ that’s affected. And we’ve been fundraising that way too–pitting lung cancer against breast cancer against childhood cancers. But what if this view of cancer is totally...
Read More
In a nutshell The authors evaluated the factors associated with improved outcomes in patients with lung cancer treated with stereotactic body radiotherapy (SBRT). Some background Stereotactic body radiotherapy (SBRT) is a type of radiotherapy used to treat lung cancer. With SBRT, a beam of radiation is focused directly on the tumor,...
Read More
In a nutshell This study compared at a new radiotherapy technique to common radiotherapy treatments for Non-small cell lung cancer patients (NSCLC). Some background Radiation therapy uses high energy radiation to kill cancer cells by damaging their DNA (the genetic material found in cells). Radiation therapy usually involves low...
Read More
In a nutshell This study looked at the usefulness of radiotherapy in combination with EGFR inhibitors in patients with advanced non-small cell lung cancer (NSCLC). Some background 66% of patients with non-small cell lung cancer (NSCLC) develop stage IV cancer, where the cancer spreads to both lungs and...
Read More
In a nutshell The authors summarized the approved guidelines obtained from the ESMO meeting on the treatment options for advanced non-small cell lung cancer. Some background In non-small-cell lung cancer (NSCLC), almost 70% of patients are diagnosed at an advanced stage of the disease. Most of these patients are unsuitable for the...
Read More
In a nutshell This study compared two treatments for early-stage non-small cell lung cancer (NSCLC): surgery and a radiosurgery treatment known as SBRT (stereotactic body radiotherapy). Some background Currently, the standard treatment protocol for early-stage (has not spread beyond the lungs) non-small cell lung...
Read More
In a nutshell This study looked at the benefits of stereotactic radiosurgery (SRS) in treating patients with lung cancer and brain metastases (cancer that has spread to the brain). Some background Lung cancer is the most common cause of brain metastases (BM). The usual treatment in this scenario is both radiation and...
Read More
